For couples undergoing IVF, the phrase “Is there anything else we can do to improve our chances?” is a common plea. Driven by the fear of failure and a desire to maximize their opportunity, many turn to “add-on” procedures—supplemental treatments beyond the standard IVF protocol. However, a landmark meta-analysis recently published in The Lancet Regional Health–Women’s Health suggests that these additions often come at a significant financial and emotional cost, despite lacking robust scientific validation.
A Rigorous Meta-Analysis Researchers from the University of Melbourne reviewed 157 studies on IVF add-ons, filtering them down to 85 high-quality trials to provide an objective assessment of their efficacy. The results were sobering: many popular adjuncts lack the clinical evidence to justify their widespread use.
Specifically, the study found insufficient or low-quality evidence for the efficacy of:
- Acupuncture
- Corticosteroids
- Endometrial Receptivity Analysis (ERA)
- Intralipid infusions
- Ovarian and endometrial Platelet-Rich Plasma (PRP) injections
- Pre-implantation Genetic Testing (PGT)
While these procedures are frequently marketed to patients as “success boosters,” the research concludes that they have not consistently demonstrated an improvement in live birth rates.
The “Maybe” List Some interventions did show a potential, albeit limited, benefit:
- Endometrial Scratching: May improve implantation rates.
- Embryo Glue: A specialized medium for embryo transfer that shows some promise in boosting success.
- PICSI (Physiologic ICSI): May reduce the risk of miscarriage by better selecting sperm, though large-scale validation is still required.
The Paradigm of Evidence-Based Decision Making IVF success rates naturally hover between 30% and 40% per cycle, and are lower for those of advanced maternal age or those facing recurrent implantation failure. This inherent limitation creates a market for “hope,” where over 70% of IVF patients in regions like the UK and Australia opt for at least one add-on procedure.
The researchers caution that the issue is not necessarily to ban these procedures, but to ensure that patients are making evidence-based decisions. Patients are often paying thousands of dollars for treatments that have not passed the bar of rigorous clinical proof.
Conclusion: Focus on Personalized Precision The most effective way to improve IVF outcomes is not by “piling on” more procedures, but by refining the foundation of the treatment.
The medical consensus is shifting:
- Stop searching for “miracle add-ons” and start focusing on personalized diagnostics.
- Analyze the root cause: Before adding expensive procedures, ensure your medical team has thoroughly investigated individual factors like ovarian reserve, embryo quality, and uterine environment.
- Choose evidence over trends: A “less is more” approach, focusing on validated protocols, is often the most realistic and cost-effective path to success.
Ultimately, the goal is not to perform more interventions, but to perform the right interventions. Hope is essential, but it must be grounded in clinical reality. For those navigating IVF, the path to a healthy baby is rarely found in the number of add-ons on an invoice, but in the precision of the care plan.
Sources: Meta-analysis published in ‘The Lancet Regional Health–Women’s Health’; research from the University of Melbourne on IVF add-ons.
Disclaimer: This report is for informational purposes. Clinical decisions regarding supplemental IVF treatments should be made following a thorough discussion with your fertility specialist regarding the potential costs and evidence-based benefits for your specific medical history.